ClinicalTrials.Veeva

Menu

Investigation of Dynamic Hyperinflation and Its Relationship With Functional Exercise Capacity in Children With Bronchiectasis

I

Izmir Bakircay University

Status

Completed

Conditions

Bronchiectasis

Treatments

Other: Evaluation of chronic cough
Other: Evaluation of peripheral muscle strength
Other: Respiratory assessment using "Spiropalm 6MWT" portable spirometry
Other: Evaluation of functional exercise capacity

Study type

Observational

Funder types

Other

Identifiers

NCT04885790
bakircaymzeren03

Details and patient eligibility

About

Prevalence of dynamic hyperinflation and its relationship with functional exercise capacity will be evaluated in children with bronchiectasis.

Full description

Exercise or hyperpnea-induced air trapping is referred to as dynamic hyperinflation. In the presence of high resistance to expiratory flows and short expiratory times, the respiratory system is unable to return to its resting volume at the end of exhalation. The positive pressure within regions of hyperinflated lung raises the mean intrathoracic pressure and causes the inspiratory muscles to operate at a higher than resting lung volume. Thus, dynamic hyperinflation places the respiratory muscles at a considerable mechanical disadvantage and further impairs respiratory function. Dynamic hyperinflation is considered to be a key determinant of exercise capacity in patients with obstructive lung diseases. Although bronchiectasis is one of the obstructive lung diseases, the presence of dynamic hyperinflation in these patients has not been adequately investigated. Management guidelines of bronchiectasis state that imaging methods or pulmonary function tests alone is not sufficient to determine the disease burden and prognosis in these patients, so they recommend including detailed evaluation of exercise tolerance in the management of bronchiectasis. Aim of this study is to investigate the prevalence of dynamic hyperinflation and its relationship with functional exercise capacity in children with bronchiectasis.

Enrollment

40 patients

Sex

All

Ages

8 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of bronchiectasis

Exclusion criteria

  • Hospitalization history during past month
  • Diagnosis of any other chronic childhood diseases such as cerebral palsy or neuromuscular diseases which may impede exercise tolerance

Trial design

40 participants in 1 patient group

Bronchiectasis
Description:
Children with bronchiectasis
Treatment:
Other: Respiratory assessment using "Spiropalm 6MWT" portable spirometry
Other: Evaluation of functional exercise capacity
Other: Evaluation of chronic cough
Other: Evaluation of peripheral muscle strength

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems